Two Phase 3 Trials of Dupilumab versus Placebo in Atopic DermatitisEric L. Simpson, Marius Ardeleanu, Thomas Bieber et al.|New England Journal of Medicine|2016Cited by 2k
Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic DisorderPatrick M. Brunner, Alain Taı̈eb, Jonathan I. Silverberg et al.|Journal of Investigative Dermatology|2016Cited by 377
Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase<scp>III</scp>trialsEric L. Simpson, Kristian Reich, Kenji Kabashima et al.|British Journal of Dermatology|2020Cited by 377
Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritusJonathan I. Silverberg, Alan Clucas, Grażyna Pulka et al.|Journal of Allergy and Clinical Immunology|2019Cited by 268
Phosphorylated p38 <scp>MAP</scp> kinase expression by leucocytes is increased in allergic humans and associated with <scp>IgE</scp> responsesJonathan I. Silverberg, Rauno Joks|Scandinavian Journal of Immunology|2023Cited by 1